Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 430022, China.
Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1281-1286. doi: 10.1007/s00259-020-04734-w. Epub 2020 Feb 22.
The aim of this case series is to illustrate the F-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China.
We describe the F-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients' medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19.
All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high F-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism.
Although F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases.
本病例系列旨在展示中国湖北省武汉市 COVID-19 引起的急性呼吸道疾病患者的 F-FDG PET/CT 表现。
我们描述了 4 名患者的 F-FDG PET/CT 结果,这些患者于 2020 年 1 月 13 日至 1 月 20 日因呼吸道症状和发热住院,当时 COVID-19 疫情尚未得到认识,病毒感染性未知。对患者的病史、临床和实验室数据以及影像学表现进行回顾性分析,强烈提示 COVID-19 的诊断。
所有患者均有两个以上肺叶的外周磨玻璃影和/或肺实变。肺部病变表现为高 F-FDG 摄取,并有淋巴结受累的证据。相反,没有播散性疾病,这一发现表明 COVID-19 具有肺嗜性。
尽管 F-FDG PET/CT 不能常规用于紧急情况下,一般不建议用于传染病,但我们的初步数据阐明了这种影像学技术在复杂病例鉴别诊断中的潜在临床应用价值。